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Abstract Formation of dityrosine bridges is a ubiquitous 
process mainly attributed to oxidative stress leading to protein 
degradation and cellular damages. Here we show that dityrosine 
formation is involved in a physiological process, thyroid hormone 
synthesis, and is strictly dependent on structural characteristics, 
namely N-glycans, presented by the protein acting as the 
prothyroid hormone. We used two isoforms of the N-terminal 
thyroid hormone forming domain (NTD) of human thyroglobu- 
lin: one without N-glyean (19 kDa isoform) and the other with 
high mannose type structures (25 kDa isoform). Both isoforms 
were able to form iodotyrosines after in vitro iodination. 
However, iodotyrosine coupling to form thyroxine did not occur 
with the unglycosylated 19 kDa NTD. In contrast, the 25 kDa 
isoform formed thyroxine. Strikingly, thyroxine synthesis was 
accompanied by dimerization of the 25 kDa isoform and 
formation of a dityrosine bridge; none of this was observed with 
the 19 kDa isoform. Taken as a whole, our results indicate that 
dimerization through dityrosine bridging accompanies and could 
have a role in thyroid hormone synthesis. 
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ecular heterogeneity. This precludes detailed analysis of the 
various domains in terms of structure-activity relationship. 
To circumvent his problem, we focused on the N-terminal 
domain (NTD) of human Tg, which contains the preferential 
site of hormone synthesis located at Tyr 5 [4]. This peptide, 
obtained after CNBr treatment of a poorly iodinated Tg, is 
able to form hormone (T4) by in vitro iodination and iodo- 
tyrosine coupling. It has an apparent molecular mass ranging 
from 19 to 25 kDa according to the number of oligosacchar- 
ide side chains linked at Asn 57 and Asn 9x [5]. The large varia- 
bility of the N-glycan structures borne by the NTD offered an 
interesting opportunity to determine the role of N-glycans in 
thyroid hormone synthesis and their possible association with 
the dimerization process through formation of dityrosine 
bridges. We selected two types of NTD:  the first was ungly- 
cosylated and the second was rich in high mannose structures. 
We observed that dityrosine bridge formation and thyroid 
hormone synthesis are both dependent on the N-glycan struc- 
tures and both the results of the same oxidative process under 
the action of TPO and the H202 generating system. 
2. Materials and mcthods 
I. Introduction 
Thyroglobulin (Tg) is a large dimeric glycoprotein 
(2 × 330 000 Da) that is the substrate for the synthesis of the 
thyroid hormones tri iodothyronine (T3) and thyroxine (T4). 
Synthesis requires the initial iodination of specific tyrosines, 
yielding either monoiodotyrosine (MIT) or diiodotyrosine 
(DIT). The possible mechanism for iodination of tyrosine res- 
idues and coupling of certain iodotyrosyl residues to form 
hormone is not fully elucidated but it is clear that in vivo 
coupling is catalyzed by thyroperoxidase (TPO) [1]. It has 
been demonstrated that this enzyme also plays a role in the 
choice of the tyrosine residues of Tg which can be iodinated 
and/or coupled to form iodotyrosines and/or thyroid hor- 
mones [2]. Leonardi et al. [3] showed that, in the case of 
bovine Tg, during this reaction of coupling, some molecules 
of Tg were dimerized by formation of dityrosine bridges and 
that this process required the presence of iodide. 
A major difficulty in studying Tg is its large size and mol- 
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2.1. Preparation of the NTD of human Tg 
Tg was purified as described previously [6] from a single euthyroid 
goiter and was then treated with CNBr. The NTD issued from this Tg 
was separated by chromatography on a Sephadex G-200 column 
(Pharmacia Biotech, Uppsala, Sweden) in 1 M propionic acid [7]. 
2.2. ConA-Sepharose chromatography 
The NTD was subjected to affinity chromatography on a ConA- 
Sepharose 4B column (Pharmacia Biotech) at room temperature. The 
column (1 x 10 cm) was equilibrated with 50 mM Tris-HC1, pH 7.4 
buffer containing 1 mM CaC12, 1 mM MgCI2 and 100 mM NaC1. 
Previously [5], we showed that the non-retained fraction was a mix- 
ture of unglycosylated NTD (19 kDa) and fully glycosylated NTD (25 
kDa) bearing two triantennary complex type oligosaccharides and 
that the fraction was eluted with an equilibration buffer. The fraction 
weakly retained by the lectin was constituted of isoforms bearing both 
bi- and triantennary complex type structures and was eluted with 10 
mM a-methyl-D-glucopyranoside. The firmly retained fraction (25 
kDa) was essentially composed of isoforms bearing high mannose 
type structures possibly associated with tri- (15%) or biantennary 
(23%) complex type structures and was eluted with 300 mM a- 
methyl-D-mannopyranoside. 
2.3. RCA12o-Sepharose chromatography 
The two isoforms of the NTD non-retained on ConA-Sepharose 
were separated on RCA120-Sepharose column after desialylation of 
these isoforms. A column containing 1ml of RCAa20 agarose (Sigma) 
was equilibrated in the same buffer as used for ConA-Sepharose chro- 
matography. The desialylated fractions were first eluted with the equi- 
libration buffer and then with the same buffer containing 20 mM 
lactose. The unglycosylated isoform was eluted in the void volume 
whereas the NTD isoforms bearing asialo-triantennary complex type 
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structures were retained on RCA120 and then eluted with 20 mM 
lactose. Mr. 10 -3 
2.4. In vitro iodination and coupling 
In a final volume of 1 ml of 50 mM Tris-HCl, pH 7.2 at 37°C was 
added 10 nmol of each fraction separated by affinity chromatography, 
1 mg glucose, 13.6 Bg KI and 10 l.tg LPO or TPO. The reaction was 
initiated by 2.5 lag glucose oxidase and stopped 30 min later by the 
addition of 0.1 M sodium hyposulfite. Excess iodide was eliminated by 
dialysis against distilled water. 
In vitro coupling was performed as described above but without 
addition of iodide in the medium. 
2.5. lodoamino acid analysis 
After digestion with protease type XXI and leucine aminopeptidase 
(Boehringer Mannheim), iodoamino acid residues were separated by 
high-performance liquid chromatography (HPLC) on a Waters Asso- 
ciated chromatograph (Milford, MA, USA) with a Vydac C18 column 
(201 TP 54; 5 mm-300 A; 4.6×250 mm). The solvent used was 
water:acetic acid (99:1) as solvent A and acetonitrile:acetic a id 
(99:1) as solvent B. After injection, the elution was performed with 
a linear gradient for 20 min. The eluate was collected (0.4 ml/tube) in 
microtubes and iodoamino acid quantification was performed accord- 
ing to O'Kennedy et al. [8]. The sensitivity of the method was 0.5 
pmol for each iodoamino acid. 
4 
2.6. Isolation of the dimer of the NTD 
About 500 mg of NTD iodinated and coupled in vitro was chro- 
matographed by HPLC with a Zorbax GF-250 size exclusion column 
(9.4x250 mm, 4 mm; Interchim, Rockland Technologies, Inc.). The 
elution was performed with a 0.05 M phosphate buffer pH 7.0 con- 
taining 150 mM NaC1. The flow rate was 0.6 ml/min. The elution was 
monitored at 280 nm and 315 nm respectively, and the eluate was 
collected in microtubes (0.2 ml/tube). 
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Fig. 1. SDS-PAGE (10% acrylamide) of the two isoforms of the 
NTD separated by affinity chromatographies as described in Section 
2. Lane 1, low molecular standards (Bio-Rad); lane 2, native 19 
kDa; lane 3, native 25 kDa; lane 4, 19 kDa after in vitro iodination 
and coupling; lane 5, 25 kDa after in vitro iodination and coupling. 
Proteins were detected by Coomassie brilliant blue staining. 
3. Results 
2. 7. Preparation of dityrosine standard 
Dityrosine was synthesized by oxidation of e-tyrosine (Sigma) with 
LPO (Sigma) according to Andersen [9]. The yield was around 2.5%. 
When dityrosine was prepared from DIT or MIT, the yield drastically 
decreased to 0.12% and a notable amount of iodine appeared in the 
medium. The purity of dityrosine was verified both by its spectro- 
photometric 0~m~x = 315 nm) and fluorometric (Ex~ ..... = 330 nm, 
Em~max --410 nm) properties and by nuclear magnetic resonance spec- 
tra. 
2.8. Other procedures 
Desialylation of the different forms of NTD non-retained on ConA- 
Sepharose column was done with 20 mU of sialidase from Vibrio 
cholerae (Boehringer Mannheim) for 24 h at 37°C in 100 mM acetate 
buffer pH 5.5 in the presence of 100 mM CaCI2. 
Amino acid analysis was done with a PicoTag system (Waters Milli- 
pore) after the sample had been hydrolyzed under vacuum in 6 N HCI 
at 110°C for 24 h. 
SDS-PAGE was performed without reduction of the sample with a 
10% acrylamide and a 1% SDS gel system. Immunoblotting was do- 
nen with a mouse monoclonal antibody directed against T4 residues; 
the second reagent was peroxidase-conjugated goat antimouse anti- 
body diluted 1/1000. 
3.1. Iodoamino acid content o f  NTD in relationship with 
N-glycans 
In this study, we investigated two characteristic forms of 
NTD:  the unglycosylated isoform (19 kDa) and the isoform 
bearing at least one high mannose type structure (25 kDa). 
These peptides were prepared from a poorly iodinated human 
Tg treated with CNBr and purified by lectin affinity chroma- 
tography. Chromatography on ConA-Sepharose column 
yielded, first, a non-retained fraction containing both isoforms 
bearing triantennary complex type structures and unglycosyl- 
ated NTD. This mixture was desialylated and put on an 
RCA120 Sepharose column. The NTD 19 kDa unglycosylated 
isoform, not retained on the column, was collected in the void 
volume. The NTD isoforms bearing at least one high mannose 
type structure were eluted from the Con A-Sepharose column 
using 300 mM ct-methyl-I>mannopyranoside after previous 
washing with 10 mM a-methyl-D-glucopyranoside to eliminate 
the isoforms bearing biantennary complex type structures (see 
Section 2). 
Table 1 
Iodoamino acid composition of the NTD unglycosylated (19 kDa) and of the NTD bearing high mannose structures (25 kDa) 
lodoamino 19 kDa 25 kDa 
acid 
Native After coupling After iodination and coupling Native After coupling After iodination and coupling 
MIT 80+6 71 +8 602+21 203+23 192+ 18 434+ 14 
DIT 18+_3 16+5 102+_28 80_+ 10 19+_6 62+_ 16 
T4 Und ~ Und Und 8 _+ 2 16 + 5 208 + 15 
Total iodine 116_+12 103_+18 806_+77 395+51 294+50 1390-+106 
For the two types of NTD, obtained from poorly iodinated Tg, iodoamino acid analysis was performed in the native form, after in vitro coupling 
and after in vitro iodination and coupling. 
Results are given as mmol of iodoamino acid residues/mol fNTD. Values are expressed asthe mean + S.D. of three experiments for 25 kDa and of 
two experiments for 19 kDa. 
aUnd = undetectable. 
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Fig. 2. After in vitro iodination and coupling of the two isoforms 
of the NTD, immunoblot was probed with anti-T4 monoclonal nti- 
body. Lane 1, unglycosylated isoform (19 kDa); lane 2, 25 kDa; 
lane 3, sample of NTD obtained from a Tg containing a high level 
of thyroxine. Detection was performed with 4-chloro-l-naphtol as 
substrate. 
For the native form of the unglycosylated NTD (19 kDa) 
and for the NTD firmly retained on ConA (25 kDa), the 
analysis of iodoamino acid residues (Table 1) showed that 
the 25 kDa contained a small amount of thyroxine and ex- 
hibited a higher degree of iodination than the 19 kDa, which 
did not contain T4. These two NTD were subjected to cou- 
pling of iodotyrosine r sidues in the presence of TPO or LPO 
and the H202 generating system but without addition of 
iodide in the medium. After coupling and in spite of the 
low level of iodination, we noted the formation of thyroxine 
hut only for the 25 kDa. This result was comparable with 
TPO and LPO as enzyme (data not shown). To amplify this 
process, we iodinated and simultaneously coupled the two 
isoforms (see Section 2). The iodoamino acid composition of 
the two in vitro iodinated and coupled NTD showed that the 
19 kDa contained more MIT and DIT residues than the 25 
kDa but these iodotyrosines were unable to form hormone 
whereas the NTD bearing high mannose structures formed 
about 0.2 mol of T4 per mol of NTD. 
3.2. Process of  dimerization of  the .NTD 
SDS-PAGE analysis of the two types of NTD identified the 
native forms of the 19 kDa and the 25 kDa (Fig. 1, lanes 2 
and 3). After coupling, the 25 kDa, which was able to form 
hormone, exhibited the presence of a new band with a molec- 
ular weight about 50 kDa (Fig. 1, lane 5). This peptide could 
correspond to a dimer of the 25 kDa. This process of dimer- 
ization was observed only for the glycosylated NTD but not 
for the 19 kDa because no band was identified in the 35-40 
kDa region. Taken together, our results how that the fraction 
able to form hormone was also able to form a peptide with a 
molecular weight corresponding to the double of NTD. After 
in vitro iodination and coupling, the two types of NTD were 
analyzed by immunoblotting with a monoclonal antibody to 
T4 (Fig. 2). The 19 kDa was not revealed because this isoform 
did not contain thyroxine, whereas the hormone-forming 25
kDa (lane 2) revealed, once again, the presence of a dimer. 
Also interesting was the presence of thyroxine in this dimer. 
During the oxidative process of the coupling, it was possible 
to create some intermolecular disulfide bridges explaining the 
formation of a dimer of the NTD. On the other hand, Leo- 
nardi et al. [3] have shown the presence of intermolecular 
dityrosine bridges in the polymers of Tg, besides the disulfide 
bridges. Accordingly, we further separated the dimer of the 
NTD in order to determine whether dityrosine was present. 
3.3. Identification of the dityrosine bridges in the dimer of  the 
NTD 
After in vitro iodination and coupling of the NTD, the 
mixture was filtered on HPLC with a Zorbax GF-250 size 
exclusion column. The elution was monitored at 280 nm 
and 315 nm (Fig. 3). The persistence of the signal at 315 
nm (corresponding to the )Vm~x of pure dityrosine) in the dimer 
of the NTD suggested that dimerization of the peptide was, in 
part, caused by intermolecular dityrosine bridges. To gain in- 
sight into the number of intermolecular dityrosine bridges 
involved in the dimerization process, the NTD dimer was 
acid hydrolyzed and dityrosine was analyzed by spectrofluo- 
rometry. The dimer contained 0.18 mol of dityrosine residue 
per molecule of dimer. This result shows that some specific 
forms of NTD were able to form at least one dityrosine bridge. 
4. Discussion 
Among the numerous tyrosine residues of Tg that can be 
iodinated, only a few are involved in hormone formation. The 
strict specificity of the hormone-forming sites obviously re- 
quires not only consensus equences [10] but also stringent 
spatial organization of the Tg molecule, which is modified 
by the degree of iodination [11] and by the type of N-glycans 
linked to Tg [12]. This specific organization of the molecule is 
essential because the formation of thyroid hormones from free 
diiodotyrosines has been unsuccessful so far whereas in the 
same conditions dityrosine formation is possible with free ty- 
rosines, the presence of iodide enhancing the coupling [13]. On 
the other hand, it has been shown that the formation of di- 
tyrosine bridges in Tg was also associated with the presence of 
iodide [3] but until now this dimerization process has never 
been studied with respect to hormone synthesis and the nature 
of the carbohydrate moieties. 
In this work, we used the N-terminal domain of human Tg 
because after separation from the core molecule, this peptide 
maintains most of its initial three-dimensional conformation, 
as demonstrated by surface epitope mapping [14]. Further- 
more, it remains able to form thyroid hormone according to 
the type of N-glycan structures borne at Asn 57 and Asn 91 [5]. 
Notably, the NTD isoforms bearing at least one high man- 
nose type structure are the richest in T4 residues while the 
unglycosylated isoform is devoid of T4. It has been previously 
shown that thyroid hormone formation can be obtained from 
a chemically iodinated Tg with few if any T4 residues, after 
incubation with TPO or LPO [15,16]. Similar results are re- 
ported here regarding the 25 kDa NTD which formed T4 
without addition of iodide in the incubation medium. More 
interesting is the observation that, in the same conditions, the 
25 kDa is also able to form intermolecular dityrosine bridges. 
By coupling of the two native forms of the NTD, only the 25 
kDa containing 0.3 atom iodide per mol of NTD formed a 
dimer, whereas the 19 kDa containing 0.1 atom iodide per 
mol of NTD did not. However, the role of iodide could be 
minor in this process of dimerization because after iodination 
and coupling of the two types of NTD, the 19 kDa NTD 
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Fig. 3. HPLC analysis of the NTD in vitro iodinated and coupled. 
About 500 pg of T4-NTD was chromatographed on a Zorbax GF- 
250 size exclusion column (250×8 mm) equilibrated in phosphate 
buffer pH 7.0. The elution was performed at room temperature and 
at a flow rate of 0.6 ml/min. The absorbance was monitored at 280 
nm (A) and 315 nm (B). Peak 1 with a retention time of 17'52 cor- 
responded to the dimer of the NTD, and peak 2 with a retention 
time of 22'51 represented the NTD. 
contained 0.8 atom of iodide per mol of NTD and remained 
unable to create dityrosine bridges. 
The oxidative reaction catalyzed by TPO or LPO results in 
coupling of iodotyrosines to form T4 and of tyrosines to 
create dityrosine bridges. These reactions are very similar. In 
both cases two molecules of the monophenolic substrates be- 
have as single electron donors, producing free radicals of the 
substrate, which then undergo radical addition to form the 
3,3'-biphenyl derivative in the case of dityrosine and 4,1'-bi- 
phenyl ether in the case of thyroid hormone: specific DIT 
residues would form T4 and specific tyrosine residues would 
form dityrosine. Indeed only tyrosine residues are able to 
form a 3,3'-dityrosine bridges while iodotyrosyl forms are 
poorly efficient (see Section 2). The most intriguing result of 
the present work is that iodotyrosine coupling and dityrosine 
formation appeared equally dependent on structural features 
of NTD isoforms: both are observed with the 25 kDa isoform 
and none with the unglycosylated 19 kDa isoform. Further- 
more the dimer formation is not restricted to the NTD bear- 
ing high mannose type structures. Dimerization was also ob- 
served, but with a lower efficiency, with the other isoforms of 
the glycosylated NTD bearing complex type structures (data 
not shown). 
Dimerization of a protein through formation of dityrosine 
bridges is not specific to the Tg molecule. Several proteins 
tbrm dityrosine bridges, either to harden the extracellular 
coat of fertilized sea urchin eggs [17] and yeast spore walls 
[18] or as the result of oxidative stress in the course of degen- 
erative and inflammatory diseases [19,20]. In the latter case, 
dityrosine formation is a marker of oxidative damage and 
aging of proteins which may be selectively degraded by intra- 
cellular proteases [21]. In the case of the N-terminal domain 
of Tg, formation of dityrosine bridges is also the result of a 
reaction of oxidation. However, several ines of evidence in- 
dicate that this reaction is part of a physiological process: 
dityrosine formation and thyroid hormone synthesis occur 
in the same conditions; both reactions are dependent on con- 
formational structure of the prothyroid hormone peptide; 
TPO and the H202 generating system are normally present 
in the thyrocyte. 
Our results extend the significance of the formation of in- 
termolecular dityrosine bridges which could be a signal for 
routing and/or degradation of proteins not only in pathologi- 
cal but also in physiological processes. 
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